Involvement of P2Y receptors in the differentiation of haematopoietic cells

Journal of Leukocyte Biology

Volumn 73, Issue 4, 2003, Pages 442-447

  Sak, Katrin ^a,b   Boeynaems, Jean Marie ^b,c   Everaus, Hele ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c ERASME HOSPITAL   (Belgium)

Author keywords

Maturation of blood cell; Nucleotide; Purinoceptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CALCIUM ION; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y12 RECEPTOR; PURINE P2Y13 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE; PURINE P2 RECEPTOR;

BLOOD CELL; BONE MARROW CELL; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL SELECTION; DEGRANULATION; DENDRITIC CELL; ERYTHROID CELL; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; LYMPHOID CELL; MEGAKARYOCYTE; MONOCYTE; MYELOBLAST; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION; ANIMAL; CYTOLOGY; HEMATOPOIETIC STEM CELL; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; HEMATOPOIETIC STEM CELLS; HUMANS; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 0038320652     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1102561     Document Type: Review

References (99)

1. Ralevic, V., Burnstock, G. (1998) Receptors for purines and pyrimidines. Pharmacol. Rev. 50, 413-492.
2. Burnstock, G. (1997) The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36, 1127-1139.
3. Hourani, S. M. O., Hall, D. A. (1994) ADP receptors on human blood platelets. Trends Pharmacol. Sci. 15, 103-108.
4. 2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. Natl. Acad. Sci. USA 91, 3275-3279.
5. Communi, D., Janssens, R., Robaye, B., Zeelis, N., Boeynaems, J-M. (2000) Rapid up-regulation of P2Y messengers during granulocytic differentiation of HL-60 cells. FEBS Lett. 475, 39-42.
6. Conigrave, A. D., Lee, J. Y., van der Weyden, L., Jiang, L., Ward, P., Tasevski, V., Lutrell, B. M., Morris, M. B. (1998) Pharmacological profile of a novel cyclic AMP-linked P2 receptor on undifferentiated HL-60 leukemia cells. Br. J. Pharmacol. 124, 1580-1585.
7. Conigrave, A. D., van der Weyden, L., Holt, L., Jiang, L., Wilson, P., Christopherson, R. I., Morris, M. B. (2000) Extracellular ATP-dependent suppression of proliferation and induction of differentiation of human HL-60 leukemia cells by distinct mechanisms. Biochem. Pharmacol. 60, 1585-1591.
8. Jiang, L., Foster, F. M., Ward, P., Tasevski, V., Luttrell, B. M., Conigrave, A. D. (1997) Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells. Biochem. Biophys. Res. Commun. 232, 626-630.
9. 11 receptor. Immunol. Cell Biol. 78, 369-374.
10. Van der Weyden, L., Rakyan, V., Luttrell, B. M., Morris, M. B., Conigrave, A. D. (2000) Extracellular ATP couples to cAMP generation and granulocytic differentiation in human NB4 promyelocytic leukaemia cells. Immunol. Cell Biol. 78, 467-473.
11. Chambers, J. K., Macdonald, L. E., Sarau, H. M., Ames, R. S., Freeman, K., Foley, J. J., Zhu, Y., McLaughlin, M. M., Murdock, P., McMillan, L., Trill, J., Swift, A., Aiyar, N., Taylor, P., Vawter, L., Naheed, S., Szekeres, P., Hervieu, G., Scott, C., Watson, J. M., Murphy, A. J., Duzic, E., Klein, C., Bergsma, D. J., Wilson, S., Livi, G. P. (2000) A G protein-coupled receptor for UDP-glucose. J. Biol. Chem. 275, 10767-10771.
12. Communi, D., Janssens, R., Suarez-Huerta, N., Robaye, B., Boeynaems, J-M. (2000) Advances in signalling by extracellular nucleotides: the role and transduction mechanisms of P2Y receptors. Cell. Signal. 12, 351-360.
13. Communi, D., Suarez Gonzalez, N., Detheux, M., Brezillon, S., Lannoy, V., Parmentier, M., Boeynaems, J-M. (2001) Identification of a novel human ADP receptor coupled to Gi. J. Biol. Chem. 276, 41479-41485.
14. 6 receptor. Mol. Pharmacol. 54, 541-546.
15. Bogdanov, Y. D., Dale, L., King, B. F., Whittock, N., Burnstock, G. (1997) Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. J. Biol. Chem. 272, 12583-12590.
16. Boyer, J. L., Waldo, G. L., Harden, T. K. (1997) Molecular cloning and expression of an avian G protein-coupled P2Y receptor. Mol. Pharmacol. 52, 928-934.
17. King, B. F., Townsend-Nicholson, A., Burnstock, G. (1998) Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharml. Sci. 19, 506-514.
18. Lee, D. K., Nguyen, T., Lynch, K. R., Cheng. R., Vanti, W. B., Arkhitko, O., Lewis, T. Evans, J. F., George, S. R., O'Dowd, B. F. (2001) Discovery and mapping of ten novel G protein-coupled receptor genes. Gene 275, 83-91.
19. Wittenberger, T., Schaller, H. C., Hellebrand, S. (2001) An expressed sequence tag (EST) data mining strategy, succeeding in the discovery of new G-protein coupled receptors. J. Mol. Biol. 307, 799-813.
20. Harden, T. K., Lazarowski, E. R., Boucher, R. C. (1997) Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. Trends Pharmacol. Sci. 18, 43-46.
21. 1, receptor. Mol. Pharmacol. 54, 1118-1123.
22. 1 receptors by N6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br. J. Pharmacol. 124, 1-3.
23. 2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends Pharmacol. Sci. 16, 179-181.
24. Yegutkin, G. G., Burnstock, G. (2000) Inhibitory effects of some purinergic agents on ecto-ATPase activity and pattern of stepwise ATP hydrolysis in rat liver plasma membrane. Biochim. Biophys. Acta 1466, 234-244.
25. Jin, J., Dasari, V. R., Sistare, F. D., Kunapuli, S. P. (1998) Distribution of P2Y receptor subtypes on haematopoietic cells. Br. J. Pharmacol. 123, 789-794.
26. Jantzen, H-M., Gousset, L., Bhaskar, V., Vincent, D., Tai, A., Reynolds, E. E., Conley, P. B. (1999) Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb. Haemost. 81, 111-117.
27. 1, purinergic receptor in the human brain: striking neuronal localisation. J. Camp. Neurol. 421, 374-384.
28. 1 purinergic receptor in neurons and glial cells of the central nervous system. Brain. Res. Mol. Brain Res. 78, 50-58.
29. Ray, F. R., Huang, W., Slater, M., Barden, I. A. (2002) Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis 162, 55-61.
30. 2 purinergic receptors in strial marginal cells and vestibular dark cells. J. Membr. Biol. 185, 103-115.
31. Hollopeter, G., Jantzen. H-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R. B., Nurden, P., Nurden, A., Julius, D., Conley, P. B. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409, 202-207.
32. 1-deficient mice. Nat. Med. 5, 1199-1202.
33. 1, receptor-null mice. J. Clin. Invest. 104, 1731-1737.
34. 2 receptor gene expression on nucleotide regulation of murine epithelial Cl-transport. J. Biol. Chem. 274, 26461-26468.
35. 2 receptor (-/-) mice. J. Biol. Chem. 274, 26454-26460.
36. 1-null mice. Mol. Pharmacol., In press.
37. Foster, C. J., Prosser, D. M., Agans, J. M., Zhai, Y., Smith, M. D., Lachowicz, J. E., Zhang, F. L., Gustafson, E., Monsma Jr., F. J., Wiekowski, M. T., Abbondanzo, S. J., Cook, D. N., Bayne, M. L., Lira, S. A., Chintala, M. S. (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J. Clin. Invest. 107, 1591-1598.
38. Communi, D., Govaerts, C., Parmentier, M., Boeynaems, J-M. (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J. Biol. Chem. 272, 31969-31973.
39. Clifford, E. E., Martin, K. A., Dalal, P., Thomas, R., Dubyak, G. R. (1997) Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5′-nucleotidase in myeloid leukocytes. Am. J. Physiol. 273, C973-C987.
40. Cowen, D. S., Lazarus, H. M., Shurin, S. B., Stoll, S. E., Dubyak, G. R. (1989) Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. J. Clin. Invest. 83, 1651-1660.
41. 2-purinergic receptors in human phagocytic leukocytes. Ann. N. Y. Acad. Sci. 603, 227-245.
42. 2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J. Biol. Chem. 271, 15597-15601.
43. Kuhns, D. B., Wright, D. G., Nath, J., Kaplan, S. S., Basford, R. E. (1988) ATP induces transient elevations of [Ca2+]i in human neutrophils and primes these cells for enhanced 02-generation. Lab. Invest. 58, 448-453.
44. Seifert, R., Burde, R., Schultz, G. (1989) Activation of NADPH oxidase by purine and pyrimidine nucleotides involves G proteins and is potentiated by chemotactic peptides. Biochem. J. 259, 813-819.
45. 2A receptors. Biochem. Pharmacol. 51, 957-965.
46. Cockcroft, S., Stutchfield, J. (1989) ATP stimulates secretion in human neutrophils and HL60 cells via a pertussis toxin-sensitive guanine nucleotide-binding protein coupled to phospholipase C. FEBS Lett. 245, 25-29.
47. Cockcroft, S., Stutchfield, J. (1989) The receptors for ATP and fMetleuPhe are independently coupled to phospholipases C and A2 via G-protein(s). Relationship between phospholipase C and A2 activation and exocytosis in HL60 cells and human neutrophils. Biochem. J. 263, 715-723.
48. O'Flaherty, J. T., Cordes, J. F. (1994) Human neutrophil degranulation responses to nucleotides. Lab. Invest. 70, 816-821.
49. Stutchfield, J., Cockcroft, S. (1990) Undifferentiated HL60 cells respond to extracellular ATP and UTP by stimulating phospholipase C activation and exocytosis. FEBS Lett. 262, 256-258.
50. Wenzel-Seifert, K., Seifert, R. (1990) Nucleotide-, chemotactic peptideand phorbol ester-induced exocytosis in HL-60 leukemic cells. lmmunobiology 181, 298-316.
51. Kannan, S. (2001) Neutrophil degranulation: coactivation of chemokine receptor(s) is required for extracellular nucleotide-induced neutrophil degranulation. Med. Hypotheses. 57, 306-309.
52. Kannan, S. (2002) Amplification of extracellular nuelcotide-induced leukocyte (S) degranulation by contigent autocrine and paracrine mode of leukolriene mediated chentokine receptor activation. Med. Hypotheses 59, 261-265.
53. 2+ in human eosinophils: activation of purinergic P2Y receptors. J. Allergy Clin. Immunol. 107, 849-855.
54. Ferrari, D., Idzko, M., Dichmann, S., Purlis, D., Virchow Jr., C., Norgauer, J., Chiozzi, P., Di Virgilio, F., Luttmann, W. (2000) P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production. FEBS Lett. 486, 217-224.
55. ++ mobilization and actin reorganization in human eosinophils. Blood 95, 973-978.
56. Cowen, D. S., Berger, M., Nuttle, L., Dubyak, G. R. (1991) Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines. J. Leukoc. Biol. 50, 109-122.
57. 2 nucleotide receptor signaling in human monocytic cells: activation, desensitization, and coupling to mitogen-activated protein kinases. J. Cell. Physiol. 187, 196-208.
58. Mattana, A., Cappai, V., Alberti, L., Serra, C., Fiori, P. L., Cappuceinelli, P. (2002) ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines. Infect. Immun. 70, 4424-4432.
59. 6, nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J. Biol. Chem. 276, 26051-26056.
60. Schmid-Antomarchi, H., Schmid-Alliana, A., Romey, G., Ventura, M. A., Breittmayer, V., Millet, M. A., Husson, H., Moghrabi, B., Lazdunski, M., Rossi, B. (1997) Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. J. Immunol. 159, 6209-6215.
61. 2Y purinoceptors in human macrophages: signalling from dying cells to macrophages. Immunology 98, 220-227.
62. 11 receptor. Br. J. Pharmacol. 128, 1199-1206.
63. Adrian, K., Bernhard, M. K., Breitinger, H-G., Ogilvie, A. (2000) Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y111) during myeloid differentiation of HL60 cells. Biochim. Biophys. Acta 1492, 127-138.
64. Berehtold, S., Ogilvie, A. L. J., Bugdan, C., Mühl-Zürbes, P., Ogilvie, A., Schuler, G., Steinkasserer, A. (1999) Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleitidases. FEBS Lett. 458, 424-428.
65. Schnurr, M., Then, F., Galambos, P., Scholz, C., Siegmund, B., Endres, S., Eigler, A. (2000) Extracellular ATP and TNF-α synergize in the activation and maturation of human dendritic cells. J. Immunol. 165, 4704-4709.
66. 11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J. Immunol. 166, 7172-7177.
67. Ferrari, D., La Sala, A., Chiozzi, P., Morelli, A., Falzoni, S., Girolomoni, G., Idzko, M., Dichmann, S., Norgauer, J., Di Virgilio, F. (2000) The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J. 14, 2466-2476.
68. La Sala, A., Sebastiani, S., Ferrari, D., Di Virgilio, F., Idzko, M., Norgauer, J., Girolomoni, G. (2002) Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory, properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood 99, 1715-1722.
69. Wilkin, F., Stordeur, P., Goldman, M., Boeynaems, J-M., Robaye, B. (2002) Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur. J. Immunol. 32, 2409-2417.
70. La Sala, A., Ferrari, D., Corinti, S., Cavani, A., Di Virgilio, F., Girolomoni, G. (2001) Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J. Immunol. 166, 1611-1617.
71. Idzko, M., Dichmann, S., Ferrari, D., Di Virgilio, F., la Sala, A., Girolomoni. G., Panther, E., Norgauer, J. (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100, 925-932.
72. Hechler, B., Cazenave, J. P., Hanau, D., Gachet, C. (1995) Presence of functional P2T and P2U purinoceptors on the human megakaryoblastic cell line, Meg-01 characterization by functional and binding studies. Nouv. Rev. Fr. Hematol. 37, 231-240.
73. 2U purinoceptors in human megakaryocytic Dami cells. Blood 83, 1258-1267.
74. Conley, P., Vincent, D., Tai, A., Li, G., Chiu, E., Bhaskar, V., Kartik, A., Jantzen, H-M. (1995) Cloning of a novel purinoceptor from a human megakaryocytic cell line. Blood 86 (Suppl 1), 361a.
75. Gachet, C., Cattaneo, M., Ohlmann, P., Hechler, B., Lecchi, A., Chevalier, J., Cassel, D., Mannucci, P. M., Cazenave, J. P. (1995) Purinoceptors on blood plalelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br. J. Haematol. 91, 434-444.
76. Jin, J., Daniel, J. L., Kunapuli, S. P. (1998) Molecular basis for ADP-induced platelet activation. J. Biol. Chem. 273, 2030-2034.
77. Kunapuli, S. P. (1998) Multiple P2 receptor subtypes on platelets: a new interpretation of their function. Trends Pharmacol. Sci. 19, 391-394.
78. 1 receptors is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation. Thromb. Haemost. 81, 775-781.
79. Zhang, F. L., Luo, L., Gustafson, E., Lachowicz, J., Smith, M., Qiao, X., Liu, Y. H., Chen, G., Pramanik, B., Laz, T. M., Palmer, K., Bayne, M., Monsma Jr., F. J. (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J. Biol. Chem. 276, 8608-8615.
80. Puri, R. N., Colman, R. W. (1997) ADP-induced platelet activation. Crit. Rev. Biochem. Mol. Biol. 3, 437-502.
81. 2 purinergic receptors on human erythro leukemia cells. J. Recept. Signal Transduct. Res. 16, 209-224.
82. Murgo, A. J., Sistare, F. D. (1992) K562 leukemia cells express P2T (adenosine diphosphate) purinergic receptors. J. Pharmacol. Exp. Ther. 261, 580-585.
83. Shi, X-P., Yin, K-C., Gardell, S. J. 11995) Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor. Thromb. Res. 77, 235-247.
84. Porzig, H., Gutknecht, R., Kostova, G., Thalmeier, K. (1995) G-protein-coupled receptors in normal human erythroid progenitor cells. Naunyn Schmiedebergs Arch. Pharmacol. 353, 11-20.
85. 2Y, purinergic receptor that couples to phospholipase C. Mol. Pharmacol. 46, 8-14.
86. 2Y purinoceptors. Mol. Pharmacol. 35, 526-532.
87. 2Y-purinergic receptor. J. Biol. Chem. 265, 13515-13520.
88. 2Y purinergic receptor agonists and guanine nucleotides. J. Biol. Chem. 264, 884-890.
89. 1 receptor: pharmacological, signaling, and molecular properties. Drug Dev. Res. 39, 253-261.
90. Dubyak, G. R., El-Moatassim, C. (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol. 265, C577-C606.
91. Ferrari, D., Munerati, M., Melchiorri, L., Hanau, S., Di Virgilio, F., Baricordi, O. R. (1994) Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients. Am. J. Physiol. 267, C886-C892.
92. 2Y-purinergic receptors. Biochem. J. 304, 769-774.
93. Baricordi, O. R., Ferrari, D., Melchiorri, L., Chiozzi, P., Hanau, S., Chiari, E., Rubini, M., Di Virgilio, F. (1996) An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87, 682-690.
94. 2-purinoceptors. J. Immunol. 146, 1626-1632.
95. Somers, G. R., Hammet, F. M. A., Trute, L., Southey, M. C., Venter, D. J. (1998) Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. Lab. Invest. 78, 1375-1383.
96. 2Z-type purinoceptor during differentiation. J. Immunol. 157, 1371-1380.
97. + T lymphocytes. J. Immunol. 169, 15-21.
98. 11 receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. Eur. J. Pharmacol. 426, 157-163.
99. Miller, J. S., Cervenka, T., Lund, J., Okazaki, I. J., Moss, J. (1999) Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor. J. Immunol. 162, 7376-7382.